1. SCIDOT-06. TOWARDS EXCLUSIVELY LOCAL THERAPY OF GLIOBLASTOMA - ENGINEERING IL-12Fc WITH SUPERIOR TISSUE RETENTION AND MINIMAL SYSTEMIC EXPOSURE AFTER CNS ADMINISTRATION. (11th November 2019) Authors: Beffinger, Michal; Schellhammer, Linda; Pantelyushin, Stanislav; Zimmermann, Iwan; Egloff, Pascal; Buch, Thorsten; Seeger, Markus; vom Berg, Johannes Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DDRE-48. COMPARTMENT LOCKED IL-12 - INCREASED TISSUE RETENTION AND MINIMAL PERIPHERAL EXPOSURE ALLOW HIGHER TREATMENT EFFICACY AND TOLERABILITY IN LOCAL GLIOBLASTOMA THERAPY. (12th November 2021) Authors: Beffinger, Michal; Schellhammer, Linda; Shekarian, Tala; Deplazes, Sereina; Zimmermann, Ivan; Egloff, Pascal; Buch, Thorsten; Seeger, Markus; Hutter, Gregor; Vom Berg, Johannes Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Biparatopic sybodies neutralize SARS‐CoV‐2 variants of concern and mitigate drug resistance. (7th March 2022) Authors: Walter, Justin D; Scherer, Melanie; Hutter, Cedric A J; Garaeva, Alisa A; Zimmermann, Iwan; Wyss, Marianne; Rheinberger, Jan; Ruedin, Yelena; Earp, Jennifer C; Egloff, Pascal; Sorgenfrei, Michèle; Hürlimann, Lea M; Gonda, Imre; Meier, Gianmarco; Remm, Sille; Thavarasah, Sujani; van Geest, Geert; ... Journal: EMBO reports Issue: Volume 23:Number 4(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗